Prevalence and rational use of polypharmacy in elderly patients in psychiatric hospitals: a review and discussion
10.3760/cma.j.issn.0254-9026.2025.02.007
- VernacularTitle:老年精神疾病住院患者多重用药现状与合理使用的探讨
- Author:
Mengxi NIU
1
;
Shanshan LIU
;
Hongyan ZHUANG
;
Yannan ZANG
;
Shuang BAO
;
Fei JIA
;
Pengfei LI
;
Qinge ZHANG
Author Information
1. 首都医科大学附属北京安定医院 国家精神疾病医学中心 国家精神心理疾病临床医学研究中心 精神疾病诊断与治疗北京市重点实验室，北京 100088
- Publication Type:Journal Article
- Keywords:
Polypharmacy;
Mental disorders;
Drug therapy;
Drug interactions;
Inpatients
- From:
Chinese Journal of Geriatrics
2025;44(2):149-155
- CountryChina
- Language:Chinese
-
Abstract:
In the context of aging population, the issue of polypharmacy among elderly patients with mental disorders has become increasingly prominent.Cognitive decline and depressive symptoms render these patients more vulnerable to medication-related risks, while poorly managed physical illnesses further complicate their treatment.To address these challenges, this paper proposes a series of management strategies that emphasize the critical role of pharmacists in conducting medication reviews.A comprehensive assessment of drug risks, benefits, and patient adherence is essential.The proposed strategies not only require careful consideration of patients' clinical needs and individual preferences but also highlight the importance of multidisciplinary team collaboration to reach a consensus on medication therapy.The use of clinical decision support systems as an auxiliary tool is recommended to enhance the scientific rigor of medication decision-making.Furthermore, pharmacists can optimize medication regimens through scientifically validated methods and promote patient or family involvement in self-management to improve acceptance and adherence to treatment adjustments.
